Clinical Trial Update: Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 study evaluating the clinical utility of liquid biopsy in patients with ALK-positive non-small cell lung cancer treated with brig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Brigatinib (brigatinib)

Snippet

Sponsor: Fundación GECP | Conditions: Lung Cancer, NSCLC | Phase 2 | Status: ACTIVE_NOT_RECRUITING